Cognitact participated the 36th Annual Scientific Meeting of the Hong Kong Neurological Society from October 28 to 29 this year
During the event, we learned a lot about the latest technology in cognitive health in Hong Kong and listened to clinical research sharing on diseases by foreign specialists.
The significance for our company is to
bring the application information of PlasmarkAD® for early detection of
Alzheimer's disease to neurologists, popularize the benefits of our technology,
and promote testing to those in need.
